SIEMENS INVESTS IN DIGITAL PATHOLOGY, BUYS STAKE IN BIOIMAGENE
IMAGING AND RADIOLOGY GIANT SIEMENS just made an interesting investment in digital pathology systems. On October 16, Siemens Venture Capital (SVC) revealed that it had purchased a stake in BioImagene Inc. (www.bioimagene.com) of Cupertino, California. The amount of the investment was not disclosed.
The timing of this
CEO SUMMARY: Digital pathology imaging systems are finding uses in all phases of drug discovery (discovery, pre-clinical, clinical trials), as well as education, research, and clinical. One hurdle to widespread adoption of fully digitized, whole-slide pathology imaging systems is FDA clearance that allows the use of this technology for primary diagnosis. Executives at two of
IMMEDIATELY AFTER GENERAL ELECTRIC ANNOUNCED its partnership with the University of Pittsburgh Medical Center (UPMC) on June 5 to develop a fully integrated digital pathology system, we took a closer look at how some pioneering pathologists are using digital imaging systems in their daily clinical practice.
What we found is that the technology is fairly well